返回 Agenda
Session 3 - Lecture 3
Session Chair(s)
Rei Maeda
Consultant
Independent Consultant for Drug PV, Japan
Speaker(s)
Session 3-1-Presentation
Kei Sagawa
Daiichi Sankyo Co., Ltd., Japan
Pharmacovigilance, Safety and Risk Management Department
Session 3-2-Presentation
Shintaro Hiro, PHD
Pfizer R&D Japan, Japan
Manager, Data Science & Analytics Japan Lead, Clinical Statistics